We have developed a method for stabilisation of polyelectrolyte gene delivery vectors by crosslinking their surfaces with biodegradable multivalent copolymers based on N-(2-hydroxypropyl)methacrylamide (HPMA). The resulting nanoparticulate vectors resist attack by serum proteins and can be modified for cell-specific delivery by incorporation of targeting ligands onto the polymer coating. Here we show that vascular endothelial growth factor (VEGF), transferrin and basic fibroblast growth factor (bFGF) can each be linked to polyHPMA-coated poly(L-lysine)/DNA complexes. All ligandtargeted complexes demonstrated increased uptake into receptor-positive cells (measured using plasmids containing 32 P-dCTP), that could be antagonised with excess free ligand. Targeted complexes also showed increased trans-
Introduction
Rapid progress in understanding the molecular pathology of many diseases increases the feasibility of therapeutic strategies involving gene replacement and supplementation. 1 However, routine clinical application of gene therapy demands the use of gene delivery vectors that are safe, efficient and non-toxic. Consequently there is an urgent need to develop efficient synthetic delivery systems, avoiding the immunological complications implicit in the use of viral vectors. 2 Self-assembling vectors based on synthetic polymers show particular promise since their physicochemical and biological properties can be easily manipulated, [3] [4] [5] and they are known to present DNA in a form suitable for transcription following arrival in the nucleus of target cells. [6] [7] However, their overall ability to mediate transgene expression is low compared with viruses, mainly due to inefficient delivery of DNA into target cells, and particularly because of the difficulty of gaining access to the target cell nucleus.
Recently we have developed a method to modify the fection, resistant to inhibition by serum, suggesting the possibility of effective application in vivo. Analysis using fluorescence microscopy confirmed enhanced uptake of ligand-targeted complexes (using Texas Red-labelled plasmid DNA), although VEGF-and transferrin-targeted complexes were restricted to cytoplasmic or perinuclear distributions. In contrast, bFGF-targeted complexes showed efficient delivery into the nucleus, with accumulation of more than 100 000 plasmids per cell within distinct intranuclear compartments. This method permits versatile targeting of genes to selected cells and may also permit manipulation of intracellular trafficking. It should find several important applications in gene delivery systems both in vitro and in vivo. Gene Therapy (2000) 7, 1337-1343.
surface of polymer/DNA vectors, protecting them against disruption by plasma proteins 8 in order to extend systemic circulation times to enhance access to widespread and disseminated target cells. [9] [10] [11] This method involves surface modification of polymer/DNA complexes using multivalent hydrophilic polymers, and yields coated complexes with a modified surface charge and decreased non-specific interaction with cells and tissues. Careful regulation of synthetic procedures permits maintenance of a small proportion of reactive groups on the hydrophilic polymers for reaction with targeting ligands added to the complexes after the coating reaction is mostly completed (Figure 1 ). In this way small amounts of proteins or peptide groups can be added to a solution of DNA complexes and become incorporated on to the surface. The proteins incorporated should be available to mediate binding to cell surface receptors, endowing the DNA complexes with the possibility of cell-specific targeting. [12] [13] In this study we have incorporated various targeting ligands on to the surface of polymer-coated poly(L-lysine) (pLL)/DNA complexes, and examined the resulting uptake and intracellular routing within target cells, together with the ability of the targeted complexes to mediate transgene expression. The targeting ligands examined are transferrin, basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF). 
Results
Physicochemical characterisation of polymer-coated pLL/DNA complexes pLL/DNA complexes were allowed to self-assemble spontaneously and targeting agents were incorporated on to the surface of the polyplex via a multivalent hydrophilic polymer (Figure 1 ). Increasing additions of targeting agent led to greater incorporation. For example, when biotinylated transferrin (molar ratio 2:1) was added at a concentration of 100 g/ml, analysis of biotin in filtered complexes using HABA 14 (2-hydroxyazobenzene-4Ј-carboxylic acid) indicated incorporation of 22.1 g/ml transferrin. This compared with less than 3 g/ml under the same conditions using complexes pretreated with aminoethanol to prevent subsequent covalent linkage ( Figure 2 ). The surface charge of the transferrin-modified complexes was also determined (measured as zeta potential, Figure 2) , and was found to decrease with increasing amounts of transferrin incorporated ranging from −3 mV (no transferrin) to −18 mV at 24 g/ml transferrin. Comparable results were obtained following the incorporation of other targeting ligands.
Photon correlation spectroscopy (PCS) was used to measure the size of complexes produced. Non-targeted complexes gave an average diameter of 60 nm (Figure 2 ), only slightly larger than unmodified pLL/DNA complexes. 3 Incorporation of transferrin led to increases in size, ranging from 101 to 353 nm following incorporation of 3-24 g/ml transferrin.
Association of targeted complexes with cells in vitro pHPMA-coated pLL/DNA complexes were formed containing a trace of 32 P-labelled DNA, surface modified with targeting ligands and association was monitored with cells in vitro. Upon incubation with ECV304 cells in serum-free medium, unmodified coated complexes showed low rates of cell association (Figure 3a) . Complexes modified with bFGF, transferrin or VEGF showed two-, three-and four-fold increased rates of association, respectively, with cellular levels continuing to rise rapidly for 4 h in each case. The presence of serum showed little effect on the levels of association achieved, indicating no inhibition by serum proteins. bFGF-, transferrinand VEGF-targeted complexes showed association levels in serum that were increased approximately 2.5-, fourand three-fold compared with untargeted controls (Figure 3b ). The amount of targeting agent added during the coating process had a significant effect on the cell association levels at 4°C (Figure 4 ). Adding increasing amounts of transferrin to complexes, without subsequent purification, led to increased rates of cell association ( Figure 4a ) that reached a maximum following addition of 1250 g/ml and fell thereafter, probably due to competition by excess (unbound) transferrin. bFGF showed similar effects, although the ligand was less freely available and competing concentrations could not be taken as high as with transferrin ( Figure 4b ). To demonstrate ligand-specific cell association, coated complexes (surface-modified with 22.1 g/ml transferrin) were purified by dialysis and added to ECV304 cells preincubated in 0-10 mg/ml transferrin. A clear inhibition of cellassociation was observed at higher concentrations ( Figure 5 ).
Transfection of target cells in vitro
The ability of complexes to transfect cells was examined in HUVE, K562, BHK and ECV304 cells. In all cell lines simple pLL/DNA complexes gave very low levels of gene expression, and polymer-coated pLL/DNA complexes gave even lower levels ( Figure 6 ), probably due to decreased non-specific uptake. Attachment of targeting ligands always increased transgene expression, although precise levels attained depended on target cells. For example, bFGF gave highest transfection of all cell types except K562 cells where transferrin was most efficient. The effects of including chloroquine on transfection activity was assessed in BHK and HUVE cells, and typical results are shown in Figure 7 . The greatest stimulation of transfection activity was obtained using simple pLL/DNA complexes, or polymer-coated complexes modified with transferrin or VEGF, all of which showed at least 10-fold stimulation by chloroquine. In contrast, complexes modified with bFGF routinely showed only two-to three-fold stimulation of activity.
In the absence of serum the level of transgene expression attained by bFGF-targeted complexes in cells was always substantially lower than the level attained by DOTAP/DNA. However, the presence of serum significantly inhibited DOTAP-mediated gene expression in most cell types, and the level attained by bFGF-targeted complexes was higher (except for ECV304). Similar effects were observed with other targeting ligands indicating serum resistance of these receptor-mediated transfection agents. It was also shown that a covalent linkage is required between the targeting agent and the polymer/DNA complex, since the addition of the targeting ligand to complexes following aminolysis (see Methods) gave no transfection activity.
Intracellular routing of polymer-coated complexes in target cells
Complexes were labelled by incorporating Texas ReddUTP into the plasmid DNA. Targeting agents were attached and complexes were incubated with ECV304 cells for 30 min. Cells were then washed and intracellular distribution examined by fluorescence microscopy after various times (Figure 8 ). The distributions of Texas Red in non-targeted complexes were similar after 30 min and 4 h, with fluorescence restricted to the outside of the cell and the remainder showing a perinuclear distribution, possibly associated with vesicles. VEGF-and transferrintargeted complexes produced greater levels of fluorescence with essentially similar distributions (data not shown). bFGF-targeted complexes were also largely restricted to the outside of the cell after 30 min. However, in 30% of the cells, almost all cell-associated Texas Red fluorescence was localised within the nucleus after 4 h. Z-series sectioning of several individual cells confirmed that the Texas Red-DNA was contained within approximately 1-9 distinct intranuclear compartments per cell. A typical Z series is shown in Figure 9 .
When bFGF-targeted complexes were formed using both DNA labelled with Texas Red and reactive polymer pre-labelled with fluorescein, evaluation of cellular distribution after 4 h again showed the DNA was mainly within the nucleus of ECV304 cells. The fluorescein-polymer also showed strong intranuclear staining, coincident with the Texas Red signal (Figure 10 ). There was also some evidence of extranuclear fluorescein signal, probably reflecting polymer that was not covalently linked to the complexes. These data indicate that the bFGF-tar-
Figure 9 Evaluation of intracellular distribution of bFGF-targeted pHPMA-coated pLL/Texas Red-DNA after 4 h within individual ECV304 cells using a Z series of images deconvoluted using Improvision software to represent slices 1 m apart.

Figure 10 Co-localisation of FITC-labeled pHPMA (b) with Texas Red-DNA (c) 4 h after application of bFGF-targeted FITC-pHPMA-coated pLL/Texas Red-DNA complexes to DAPI stained ECV 304 cells (a).
Images shown represent the same central 1 m slice deconvoluted using Improvision software.
geted complexes are reaching and entering the nucleus intact.
Discussion
In this study, we have shown that simple covalent linkage of targeting ligands to polymer-coated pLL/DNA complexes can deliver them to target cells in vitro via specific receptor interactions, achieving internalisation and receptor-mediated transfection. Transferrin, VEGF and bFGF have all been used in this way, although the approach is relatively flexible since any amino-containing peptide could be used as a targeting ligand. Physicochemical properties of transferrin-modified complexes were studied in detail, and showed approximately 20% efficiency of ligand incorporation, up to a maximum incubation concentration of 100 g transferrin/ml (representing incorporation of approximately 82 transferrin molecules per plasmid). When the concentration of transferrin added was increased from 100 to 500 g/ml there was a significant increase in size, but no significant change in surface charge or amount of transferrin incorporated. This suggests that the presence of too much transferrin can cause aggregation of individual comGene Therapy plexes without increasing covalent linkage. The importance of covalent linkage formed through the reactive polymer to the targeting ligand was demonstrated by pre-treating the polymer with aminoethanol to aminolyse reactive esters. Complexes formed in this way showed no significant change in properties due to the presence of transferrin.
Receptor-mediated uptake of complexes into ECV304 cells was examined using 32 P-labelled plasmid DNA. VEGF, bFGF and transferrin all mediated elevated rates of cell association at 37°C compared with non-targeted complexes. The latter showed low levels of accumulation, probably due to fluid phase pinocytic capture. Both transferrin and bFGF-mediated uptake could be inhibited by the presence of excess ligand at 4°C, indicating specific receptor binding. The presence of serum had no measurable effect on the association of any complexes with cells at 37°C, indicating that neither the basal rate of pinocytosis nor the receptor-mediated binding and internalisation events were inhibited by serum proteins. Determination of transfection activity showed no direct relationship with levels of targeted cell-association in these cells. All targeted complexes showed increased transfection compared with controls, although bFGF was more successful than VEGF or transferrin, despite lower levels of cell association. This suggests that bFGF may play a role in intracellular processing of the complexes. The observation that transfection activity of complexes targeted using bFGF was stimulated less by chloroquine than that of VEGF-and transferrin-targeted complexes suggests less influence of endosomal compartmentalisation on limiting the transfection pathway mediated by bFGF compared with the other ligands.
Targeted transfection activity was highly resistant to inhibition by the presence of 10% serum, in contrast to the non-specific membrane-active agents such as cationic lipids or non-targeted pLL/DNA complexes. Transfection activity of complexes targeted with transferrin, VEGF and most notably bFGF was at least as high as with DOTAP in most cell lines, and often much higher, indicating potential for its application in vivo.
Analysis by deconvolution fluorescence microscopy showed that bFGF-targeted complexes were delivered into the nuclei of ECV304 cells. In contrast non-targeted complexes, or those targeted with VEGF or transferrin, were restricted mainly to extracellular and perinuclear distributions. Analysis of serial Z sections in several cells indicated the accumulation of bFGF-targeted complexes within discrete intranuclear domains. Routing of the FGF receptor to the nucleus has been documented before, particularly following ligand stimulation. [15] [16] [17] [18] [19] [20] However, nuclear delivery of engineered ligands has not been previously reported, and the high efficiency observed here is particularly surprising in view of the large size of the bFGF-targeted pLL/DNA complexes. Each complex has a diameter of at least 60 nm, and is thought to contain several plasmids 21 each with a molecular weight of 3.25 × 10 6 . Nuclear accumulation has also been reported before for bFGF itself in endothelial cells, where the growth factor is thought to be retained within the nucleus, possibly within discrete storage depots. 22 These pod-like structures bear striking similarities to the distributions observed here for bFGF-targeted complexes, and it seems plausible that the vectors are actually exploiting physiological bFGF pathways. At present the precise ana-tomical location of bFGF-targeted complexes within the nucleus is unclear, although the relatively poor level of specific gene expression observed suggests the DNA is not easily available for transcription. This may be influenced by the retention of the polymer coating on the complexes (Figure 10 ), restricting enzymatic access and the efficiency of transcription. Further studies will be focused on elucidating factors limiting transcriptional activity, to improve exploitation of this substantial intranuclear depot of transgene DNA.
The approach described here provides several possibilities for development of improved vectors for gene delivery. Several targeting agents, including mixtures, can be incorporated to modulate selectivity of delivery, and sequences can be introduced into the polymers to tailor the complexes as pro-forms for activation by specific target-associated enzymes. 23 In addition, hydrolytically unstable polymer linkages may yield the possibility of long-term release of DNA within the nuclear compartment. Finally, polyvalent surface modification with hydrophilic polymers, as well as enabling attachment of targeting agents, also permits protection of the complexes from inappropriate protein binding, one of the major factors implicated in rapid elimination from the circulation. [8] [9] [10] [11] Combination of these strategies means that systemic targeted delivery of genes for gene therapy is increasingly realistic and could soon be applied in a therapeutic context.
Materials and methods
Labeling of DNA using 32 P-dCTP or Texas Red-dUTP DNA used throughout these studies was a 5.5 kb expression vector (JL1138) encoding the ␤-galactosidase gene under transcriptional regulation of the CMV immediate-early promoter. To permit labelling with radioactivity or fluorescence the expression vector was linearised using HindIII restriction enzyme and denatured to 95°C for 3 min. For radiolabelling, 32 P-dCTP was then incorporated using the Ready-to-Go DNA labelling beads (Pharmacia Biotech, St Albans, UK). Unincorporated nucleotides were removed using MicroSpin S-300 Sephacryl columns (Pharmacia Biotech) and the purity of the labelled DNA checked by agarose gel electrophoresis and phosphorimager analysis (Molecular Dynamics, High Wycombe, UK). For fluorescence labelling, Texas Red-dUTP (Molecular Probes, Cambridge, UK) was incorporated using the same procedure, except that the kit was supplemented with dCTP (2 mm).
Synthesis of multivalent reactive polymer
A multivalent reactive hydrophilic polymer (pHPMAONp) was synthesised based on poly[N-(2-hydroxypropyl)methacrylamide] bearing randomly spaced pendent tetrapeptide (Gly-Phe-Leu-Gly) side chains (overall content 8.6 mol%) terminated in reactive 4-nitrophenyl ester groups, as described elsewhere. 24 To permit fluorescent labelling of the polymer, fluorescein isothiocyanate (FITC) was dissolved with an excess of ethylene diamine in dimethylformamide (DMF, 50% vol/vol) and allowed to react for 5 h at room temperature. Excess ethylene diamine and DMF was evaporated, solid residue was dissolved in methanol and the N-(2-aminoethyl)fluorescein-5-carboxamine product was purified by gel filtration on Sephadex LH-20 in methanol. For incorporation of fluorescein onto the polymer, N-(2-aminoethyl)fluorescein-5-carboxamine was reacted with the 4-nitrophenoxy groups of the pHPMA-ONp, in dry DMSO, 3 h at room temperature, at a level equivalent to 1 mol% of reactive ester groups in the pHPMA-ONp. The polymer was isolated by precipitation into acetonediethyl ether and purified by reprecipitation from methanol.
The remaining 4-nitrophenyl ester groups in the pHPMA-ONp react with amino groups at slightly alkaline pH, and can form covalent bonds with pLL. There is no reactivity towards DNA. 8 Formation of pLL/DNA complexes and modification with reactive hydrophilic polymers and targeting agents pLL/DNA complexes were prepared by adding appropriate volumes of pLL solution (20 kDa, 2.5 mg/ml) to plasmid DNA (20 g/ml) in water to achieve an N:P ratio of 2.0 (defined as the ratio of amino groups in the pLL to phosphate groups in the DNA). For coating with reactive polymer, the pLL/DNA complexes were allowed to stand for 1 h before addition of pHPMA-ONp (up to 200 g/ml) in HEPES buffer (final concentration 50 mm, pH 7.5). 10 Complexes were allowed to react for 2 h before addition of aminoethanol (1 l/ml) to aminolyse any remaining 4-nitrophenyl ester groups. For linkage of targeting agents to the outside surface of coated complexes, the appropriate targeting ligand was added to complexes (final concentration 10-1000 g/ml) 1 h following addition of pHPMA-ONp, and aminoethanol was added another 1 h later, as above. No purification was necessary for binding experiments, although 4-nitrophenol was removed by dialysis (Tubulisers, cut off 50 kDa, Spectrum Laboratories, Houston, TX, USA) for transfection studies, and for HABA analysis (Pierce and Warriner, Chester, UK) complexes were washed using Ultrafree MC filters (300 kDa cut off, Sigma Chemical, Poole, UK). Recovery was checked in each case by trace labelling DNA with 32 P-dCTP, and biotin was determined spectrophotometrically by displacement of HABA dye from avidin, according to the manufacturer's specification. 14 
Determination of zeta potential
The surface charge of the polymer/DNA complexes was assessed by using a Zetamaster system (Malvern Instruments, Malvern, UK). The system was routinely calibrated using a −55 mV standard. Experimental samples (5 ml Hepes buffer, 50 mM, pH 7.4) contained a final DNA concentration of 20 g/ml and were measured five times for 30 s at 1000 Hz with zero field correction. Assays were performed in triplicate.
Analysis of particle size
The size of complexes was determined using a Malvern Instruments Zetasizer with a 70 mW external laser (wavelength 488 nm). Photon correlation spectroscopy was performed at 25°C in HEPES buffer (50 mm, pH 7.4).
Cell lines and primary human umbilical vein endothelial cells Human umbilical vein endothelial (HUVE) cells were obtained from umbilical cords at the Birmingham Women's Hospital and maintained in M199 media containing 20% foetal calf serum supplemented with glutamine (2 mm) and used before passage 3. ECV304 cells (genetically identical with T24 bladder carcinoma cells), BHK transformed hamster kidney fibroblasts, and K562 human leukaemic cells were all maintained in RPMI containing foetal calf serum (10%) and glutamine (2 mm) without antibiotics.
Studies of cell association and uptake of DNA complexes ECV304 cells were seeded at 10 000 cells per well in 96-well plates and grown overnight. DNA complexes bearing appropriate targeting agents and labelled with 32 PdCTP were added in 30 l to 200 l of serum-free media per well, to a final concentration of 2.6 g DNA/ml at 37°C. After appropriate incubation times, cells were washed twice in PBS and solubilised in lysis buffer (100 l of 100 mm K 2 PO 4 , pH 7.4; 0.2% Triton X-100) for 1 h. For competition binding studies, cells were cooled to 4°C before addition of 0-10 mg/ml transferrin for 1 h, complexes were then added as above for a further 2 h. One half of the sample was used for determination of radioactive content, and the other for protein measurement using the BCA method.
Fluorescence microscopy of intracellular distribution of complexes ECV 304 cells were grown overnight on gelatin-pretreated cover slips at a density of 10 000 cells per cover slip. DNA complexes were prepared using Texas Redlabelled DNA and fluorescein-labelled pHPMA-ONp and added to cells for 30 min pulse exposure (2.6 g DNA/ml as a bubble on the cover slip). Cells were reincubated in full medium for 30 min or 4 h, washed in PBS, fixed in paraformaldehyde (4%) in PBS, washed again and mounted using Vectashield (Vector Laboratories, Burlingame, CA, USA) containing DAPI (2 g/ml). Cellular distribution of fluorescence was then determined using a Zeiss Axioskop microscope (Welwyn Garden City, UK), data captured using Improvision software and deconvoluted using OpenLab (Improvision, Warwick, UK).
Measurement of transfection activity
Cells were plated at 10 000 cells per well in 96-well plates and incubated overnight. DNA complexes were then added for 4 h at a final concentration of 2.6 g DNA/ml. Cells were then washed, reincubated in the presence of antibiotics. After 48 cells were washed and solubilised in lysis buffer (100 l of 100 mm K 2 PO 4 , pH 7.4; 0.2% Triton X-100) for 1 h and ␤-galactosidase gene expression was determined using Galactolight (Tropix, Cambridge, UK).
